U.S. Contrast Injector Market, By Product (Injector Systems, Consumables, and Accessories), Application (Radiology, Interventional Radiology, and Interventional Cardiology), Modality (Dual-Head, Single Head, and Syringeless Injectors), Design (Pedestal Mounted, Ceiling Mounted, and Standalone), End-User (Hospital, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender and Third Party Distributors) – Industry Trends and Forecast to 2030.
U.S. Contrast Injector Market Analysis and Size
The rise in chronic diseases is a significant factor contributing to the elevated demand for contrast media injectors. To meet this demand and cater to the needs of diagnostic imaging procedures, manufacturers of these injectors have been dedicating substantial efforts to Research and Development (R&D). Their aim is to introduce new products and secure approvals for new indications. This proactive approach aligns with the escalating requirement for imaging procedures, fostering further growth in the market. Moreover, advancement in healthcare infrastructure and increasing number of diagnostic procedures effectively help the growth of the contrast injector market. However, the lack of accessibility and high cost associated with devices may hamper the future growth of the contrast injector market. The partnerships and acquisitions by major market players act as an opportunity for the growth of contrast injector market.
Data Bridge Market Research analyses that the U.S. contrast injector market which was USD 268.70 million in 2022, and would rocket up to USD 443.14 million by 2030, and is expected to undergo a CAGR of 6.6% during the forecast period. This indicates that the market value. “Hospitals” dominates the end-user segment of the contrast injector market owing to the growing demand for contrast injector in hospitals. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
U.S. Contrast Injector Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Injector Systems, Consumables, and Accessories), Application (Radiology, Interventional Radiology, and Interventional Cardiology), Modality (Dual-Head, Single Head, and Syringeless Injectors), Design (Pedestal Mounted, Ceiling Mounted, and Standalone), End-User (Hospital, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender And Third Party Distributors)
|
|
Countries Covered
|
U.S.
|
|
Market Players Covered
|
Bayer AG (Germany), Guerbet (France), Bracco Imaging S.p.A (Italy), Ulrich GmbH & Co.KG (Germany), Nemoto Kyrindo Co., Ltd. (Japan), APOLLO RT Co. Ltd. (Taiwan), Shenzhen Seacrown Electromechanical Co., Ltd. (China), Shenzhen Anke High-tech Co. Ltd. (China), SINO MDTBaslan Ltd. (China), AADCO Medical Inc. (U.S.), SCW Medicath Ltd. (India), B. Braun Melsungen AG (Germany), Medline Industries Inc. (U.S.), Shenzhan Antmed Co., Ltd. (China), Sinton Medical Products (China), Radtech X-Ray, Inc. (U.S.), Metron Healthcare (U.K.), Angiodynamics Inc. (U.S.), among others
|
|
Market Opportunities
|
|
Market Definition
Contrast media injectors (CMI) are injectors used in radiology to inject contrast media agents into the bloodstream of patients for the clear visualization of various medical conditions and pathologies. These injectors are used in hospitals with X-rays, computed tomography (CT), magnetic resonance imaging (MRI), angiography systems, and other scanners.
U.S. Contrast Injector Market Dynamics
Drivers
- Increasing Prevalence of Chronic Diseases
The prevalence of chronic diseases such as cardiovascular diseases, cancer, and kidney disorders has been increasing in the United States. Contrast injectors are essential in diagnosing and monitoring these conditions, which is expected to drive demand in the market.
According to the WHO updates from July 2021, cardiovascular diseases (CVDs) are the number one cause of death globally. An estimated 17.9 million each year suffer from cardiovascular diseases. Four out of five cardiovascular deaths are due to strokes and heart attacks, and one-third of deaths occur prematurely in people under 70 years. Similarly, according to the WHO 2021 fact sheet, non-communicable diseases (NCDs), also known as chronic diseases, are responsible for the death of about 41 million people each year, which was about 71% of the total deaths recorded all over the world. As per the same source, every year, over 15 million people aged between 30-69 years die due to NCDs across the world. Thus, due to the high burden of mortality due to NCDs, the demand for diagnostic procedures is increasing.
- Rising Number of Geriatric Population
The aging U.S. population is more susceptible to various health conditions that require diagnostic imaging. This demographic trend contributes to the increasing demand for contrast injectors.
The number of persons above 65 years is projected to double in the coming years. As people age, there is an increase in the occurrence of degenerative diseases, which could be treated with diagnosis. The growing older population is expected to increase the demand for treatment procedures, thereby accelerating the growth of the contrast injector market.
- Increasing Demand for Minimally Invasive
Contrast injectors are also used in minimally invasive procedures such as interventional radiology and angioplasty. The growth of these procedures boosts the demand for contrast injectors.
One of the factors attributed to the growth of the contrast media injectors market are increasing demand for minimally invasive surgeries. Several advancements in contrast media injector technology have been made to reduce contrast media waste and automate data collection regarding the dose received by a patient. This is expected to contribute to the growth of the market studied over the forecast period.
Opportunity
- Rising Healthcare Expenditure
As healthcare expenditure in the U.S. continues to rise, healthcare facilities are more likely to invest in advanced medical equipment, including contrast injectors, to improve patient care and outcomes. The rise in healthcare expenditure helps healthcare organizations improve their facilities and equipment.
In addition, manufacturers are constantly innovating to develop more user-friendly and efficient contrast injectors. Features such as touchscreen interfaces, automation, and remote control capabilities are becoming more common.
Restraint/Challenge
- Rising Healthcare Expenditure
On the other hand, high cost of contrast media injectors and adverse effects of contrast agents are the major factors among others are expected to obstruct market growth. Moreover, Changes in healthcare reimbursement policies and rates can impact the financial viability of medical procedures using contrast injectors. This will further challenge the market in the forecast period of 2023 to 2030.
This contrast injector market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the contrast injector market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In September 2019, Bayer AG launched its Medrad Stellant Flex CT injection system. Stellant Flex is a user-driven system that requires minimal technologist training and automation. It offers individualized patient protocols and personalized imaging with flexible options for capital equipment through the company’s TechCare program
- In March 2020, ulrich medical presented a version of its CT motion contrast media injector designed for the American market. It has FDA approval and will be marketed in cooperation with partner GE Healthcare. ulrich medical already supplies its contrast media injectors to more than 60 countries. This product launch boosted the company’s existing contrast injector devices and product portfolio and helped it to attain a lucrative growth in the market
U.S. Contrast Injector Market Scope
U.S. contrast injector market is segmented on the basis of product, application, modality, design, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Injector Systems
- Consumables
- Accessories
Application
- Radiology
- Interventional Radiology
- Interventional Cardiology
Modality
- Dual-Head
- Single Head
- Syringeless Injectors
Design
- Pedestal Mounted
- Ceiling Mounted
- Standalone
End-User
- Hospital
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Others
Distribution Channel
- Direct Tender
- Third Party Distributors
U.S. Contrast Injector Market Regional Analysis/Insights
The U.S. contrast injector market is analysed and market size insights and trends are provided by product, application, modality, design, end-user and distribution channel as referenced above.
The countries covered in the contrast injector market report are U.S.
U.S. has highest market share in global market due to growing geriatric population and technology advancement in healthcare sector.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The U.S. contrast injector market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for contrast injector market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the contrast injector market. The data is available for historic period 2015 to 2020.
Competitive Landscape and Contrast Injector Market Share Analysis
The U.S. contrast injector market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company's focus related to contrast injector market.
Some of the major players operating in the U.S. contrast injector market are:
- Bayer AG (Germany)
- Guerbet (France)
- Bracco Imaging S.p.A (Italy)
- Ulrich GmbH & Co.KG (Germany)
- Nemoto Kyrindo Co., Ltd. (Japan)
- APOLLO RT Co. Ltd. (Taiwan)
- Shenzhen Seacrown Electromechanical Co., Ltd. (China)
- Shenzhen Anke High-tech Co. Ltd. (China)
- SINO MDTBaslan Ltd. (China)
- AADCO Medical Inc.(U.S.)
- SCW Medicath Ltd. (India)
- B. Braun Melsungen AG (Germany)
- Medline Industries Inc. (U.S.)
- Shenzhan Antmed Co., Ltd. (China)
- Sinton Medical Products (China)
- Radtech X-Ray, Inc. (U.S.)
- Metron Healthcare (U.K.)
- Angiodynamics Inc. (U.S.)
SKU-